Evaluating how satisfied patients are with their psoriasis treatments
Official title: Assessment of Treatment Satisfaction in Psoriasis
Funded at University of California Los Angeles · NIH-11078758 · Data updated 2026-11-12
This study is looking to see how happy people with chronic small plaque psoriasis are with their treatments, using a special tool called DermSat to gather their thoughts, so we can make care better for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | September 20, 2023 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $163,565 |
| NIH project number | 5R01AR081226-03 |
| Project ID | NIH-11078758 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with chronic small plaque psoriasis who are currently undergoing treatment.
✕Less likely to help
Patients with psoriasis who are not currently receiving treatment or those with other dermatological conditions may not benefit from this research.
What this research studies
This research focuses on understanding patient satisfaction with treatments for chronic small plaque psoriasis. It aims to validate a specialized tool called DermSat that measures treatment satisfaction from the patient's perspective. By gathering feedback from patients, the study seeks to improve clinical decision-making and enhance care delivery. Participants will be recruited from a diverse group of psoriasis patients, and their experiences will be tracked over time, including during treatment flares.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies that better align with patient preferences and enhance overall treatment adherence.
How similar studies have gone: Previous research has shown that patient-reported outcomes can significantly enhance treatment satisfaction and adherence, indicating a promising approach in this area.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Armstrong, April W — University of California Los Angeles
- Study coordinator: Armstrong, April W
Related research
Other NIH-funded projects on the same topics.
-
Testing antiplatelet approaches in psoriasis to improve blood vessel health
A study at NYU School of Medicine will test antiplatelet strategies to reduce heart and blood vessel risk in adults with psoriasis.
-
Topical immunoregulatory therapy for psoriasis
A new topical treatment for psoriasis is being developed to safely reduce skin symptoms and improve quality of life.
-
Understanding psoriasis genetic signals across diverse populations
A study to uncover the genetic factors behind psoriasis in African American people using advanced genomic and epigenetic methods.
-
SerpinB3 and keratinocytes: a new path to understanding psoriasis
This NIH grant explores how a keratinocyte protein called SerpinB3 may drive plaque psoriasis, with the hope of finding new treatments for people with moderate-to-severe disease.
-
Role of a skin protein in psoriasis-related diabetes
A study explores how a skin inflammation signal may contribute to developing type 2 diabetes in people with psoriasis.
-
How satisfied people with plaque psoriasis are with their treatments
This project will try a new questionnaire called DermSat to measure treatment satisfaction among people with plaque psoriasis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.